Baidu
map
J PHARMACOL EXP THER 润色咨询

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

出版年份:1909 年文章数:7065 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2022-07-16 ms1000001586655204

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:神经药理
    经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2022-05-12 ms7000002017209868

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    SCI期刊是如何分区的?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    选刊时需结合IF进行吗?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2020-02-22 14841a7em34暂无昵称

    您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表:
    你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?

    130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2019-06-22 qxl路漫漫

    需要原始数据吗130****3681 2019-05-23 发表::
    这个杂志怎么样啊
    130****3681 2019-05-23 00:00:00 发表:
    这个杂志怎么样啊

    130****3681 2019-05-23 发表:: 这个杂志怎么样啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2019-05-23 1301f90d5dm

    这个杂志怎么样啊183****6078 2018-11-08 发表::
    研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高
    183****6078 2018-11-08 15:10:00 发表:
    投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高

    183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2018-11-28 12117f6cm43暂无昵称

    你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?152****6931 2017-11-22 08:21:00 发表:
    这个收版面费吗

    152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2018-11-08 1831f13977m

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:神经药理<br>经验分享:总体来说非常失望,在需要支付审稿费的情况下审了三个多月,最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:要审稿费,审稿很快,但是给拒了,推荐了另一家杂志,然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好,请问您这个问题解决了吗,我现在也遇到了这个问题,应该怎么付费呢<span class="quote">130****9643暂无昵称 2018-11-28 00:00:00 发表:<br>你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?</span>, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗<span class="quote">130****3681 2019-05-23 发表::<br>这个杂志怎么样啊</span><span class="quote">130****3681 2019-05-23 00:00:00 发表:<br>这个杂志怎么样啊</span>, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊<span class="quote">183****6078 2018-11-08 发表::<br>研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span><span class="quote">183****6078 2018-11-08 15:10:00 发表:<br>投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高</span>, beContent=183****6078 2018-11-08 发表:: 研究方向:离子通道;瘙痒; 接收率:约50% 审稿时间:约1个月 投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好,我想问一下投J PHARMACOL EXP THER杂志的时候,怎样付过去审稿费的啊?<span class="quote">152****6931 2017-11-22 08:21:00 发表:<br>这个收版面费吗</span>, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一篇,靶点清楚,机制涉及不是很深,审稿人评论实验设计合理,小修,从投稿到接收共29天,效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-22 1521f0930bm

    这个收版面费吗

    0

共24条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map